Abstract
The spread of bacterial resistance leads to a growing demand for novel antibiotics. However, despite significant efforts in academia and the pharmaceutical industry, no genuinely new class of antibacterial compounds has reached the market for almost 20 years.

This publication has 0 references indexed in Scilit: